Keywords: lehman, brothers, boosts, peak, sales, forecasts, gsk

Lehman Brothers boosts peak sales forecasts of GSK drugs after R&D review

Article | 27 June 2005

Print This

Lehman Brothers has reviewed its forecasts for a number of pipeline projects at UK drug major GlaxoSmithKline, the second largest ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in